Affiliation:
1. Department of Radiotherapy, Weifang Peoples HospitalWeifangP.R. China
2. Department of Reproduction, Weifang Peoples HospitalWeifangP.R. China
Abstract
Gamma ray can promote cancer cell apoptosis and cell cycle arrest. It is often used in the clinical treatment of tumors, including lung cancer. In this study, we aimed to explore the role of gamma ray treatment and its correlation with BTG2 in cell proliferation, apoptosis, and cell
cycle arrest regulation in a lung cancer cell line. A549 cell viability, apoptosis rate, and cell cycle were investigated after gamma ray treatment. We then used siRNA for BTG2 to detect the effect of BTG2 knockdown on the progress of gamma ray-treated lung cancer cells. Finally, we investigated
the signaling pathway by which gamma ray might regulate BTG2. We found that gamma ray inhibited A549 cell viability and promoted apoptosis and cell cycle arrest, while BTG2 knockdown could relieve the effect caused by gamma ray on A549 cells. Moreover, we confirmed that the effect of BTG2
partly depends on p53 expression and gamma ray-promoting BTG2 expression through the JNK/NF-B signaling pathway. Our study assessed the possible mechanism of gamma ray in tumor treatment and also investigated the role of BTG2 in gamma ray therapy. All these findings might give a deep understanding
of the effect of gamma ray on the progression of lung cancer involving BTG2.
Subject
Cancer Research,Oncology,General Medicine
Reference26 articles.
1. Evaluation of γ-radiation-induced DNA damage in two species of bivalves and their relative sensitivity using comet assay;Aquat Toxicol.,2014
2. DNA damage in hair root cells as a biomarker for gamma ray exposure;Mutat Res.,2013
3. Intensity-modulated radiation therapy (IMRT) for prostate cancer: Toxicity and biochemical control in 183 Chinese patients from a single institution in Hong Kong;J Clin Oncol.,2011
4. Emotional aspects and pranayama in breast cancer patients undergoing radiation therapy: A randomized controlled trial;Asia Pac J Oncol Nurs.,2016
5. Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: Preliminary results of toxicity and biochemical control;J Exp Clin Cancer Res.,2013
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献